YBX1 and early-onset autosomal dominant Alzheimer disease: Previous studies have demonstrated that chaperone proteins, including Hsp70 and YB-1, exhibit neuroprotective effects and therapeutic benefits in mouse models of Alzheimer’s disease (AD) [132,133].